Navigation Links
Regence Enables Members to Share Feedback With Each Other When Researching Health Care Provider Options
Date:1/14/2008

Member feedback feature promotes a more informed health care experience

PORTLAND, Ore., Jan. 14 /PRNewswire/ -- National and regional studies indicate that informed patients make better health care decisions, and to promote this effort, Regence is launching a member feedback feature in Spring 2008 that enables the health plan's three million members to share information with each other about their provider experiences through myRegence.com, the company's member site.

The new feedback feature provides Regence members with the means to evaluate and review information on physicians, dentists and other health care professionals, and to see comments and ratings posted by other members. Health care providers whose patients complete the survey have an opportunity to respond online. Currently, members are able to comment on their experience with Regence as a health plan through myRegence.com.

"People often ask their family, friends and neighbors for recommendations regarding health care providers, and this feature is another way to expand the back fence in terms of those conversations," said Jeff Robertson, M.D., Executive Medical Director for Regence. "This new feature effectively broadens the resources available to our members by encouraging feedback about their health care experience."

The feedback feature will be launched in a two-step process. Regence members and guests will be able to view the numerical portion of survey results in early March 2008. In April, Regence plans to expand the feature, making the comments and numerical scores available online to members. Both elements are available to providers as part of a feature preview period that begins today.

In a study conducted among Regence members with the help of an independent research firm, 94 percent of the respondents indicated that having access to information about other individuals' experiences was important to their health care decision-making. In response, Regence c
'/>"/>

SOURCE Regence
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. myRegence.com Wins Three Gold Awards from eHealthcare Strategy & Trends
2. Regence Partners with Multnomah Education Service District to Bring Free Health Services to more than 20,000 Students in Need
3. American Heart Association Award Recognizes Regence as a Start! Fit-Friendly Company
4. American Heart Association Honors Regence BlueCross BlueShield of Utah as the States First Start! Fit-Friendly Company
5. Regence Introduces Two New Plans Designed Especially for Small to Mid-Size Companies
6. Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship
7. Regence Expands MedAdvantage Market, Hits the Road to Educate Seniors
8. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
9. Regence Offers InterM to Fill Gap for the Uninsured
10. Oosight Imaging System Enables a Breakthrough: The Viable Transfer of Genetic Material for Stem Cell Nuclear Reprogramming in Primates
11. IVF technique enables pregnancy without multiple births, Stanford researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...ey Spears has been warned to stop drinking. Accord...d that she might have done irreparable damage to ...lor John Sundahl had told her: "If you fall off th...you will live. If you don't want to get sober for ...
...hat humans distant ancestors won the battle agains... left the human species vulnerable to HIV today. ...esent century and one of the most researched one s...d about its origin. Many researchers believe that ...
...shop owner was sentenced to two years probation fo...rced the evacuation of a rooming house beside his ...nts of sexual assault and one count of sexual expl...victims testified that Claro caressed and groped t...
...ermany have died of the feared H5N1 strain of bird...of a total of 14 birds tested positive for the H5N...itute institute said. A health official, Katja Gue...t tests carried out by the same institute confirme...
Other Medicine News:Health News:Ancient Ancestors Might Have Had a Clue to HIV 2Health News:Two Year Probation for Cobra Owner Helder Claro 2Health News:Six Cases of H5N1 Bird Flu Confirmed in Germany 2
(Date:10/13/2008)...ene(R)-F Surface Treatment Maximizes,Endothelializ...or Long-Term,Dual Antiplatelet Therapy, WASHINGTO...at today,s,"Innovative Devices and Futuristic Ther...r Cardiovascular Therapeutics (TCT) scientific,sym...oundation, presented,12-month follow-up data from ...
(Date:10/13/2008)...wswire/ -- Facet Solutions, Inc. today,announced t...from its US,IDE Pilot Study. The results show a 78...res, and an 80% reduction in Visual Analog Scores ...dent & CEO for Facet Solutions,added, "We are ver... not,only demonstrate significant pain relief but ...
(Date:10/10/2008)...f., Oct. 10 /-,XTENT, Inc. ...present,long-term follow-up data from the CUSTOM I...iovascular Research Foundation,s (CRF) twentieth a...CT) meeting in Washington, DC.,The CUSTOM clinical...igate,the safety and efficacy of the Custom NX(R) ...
(Date:10/10/2008)...ire-FirstCall/ -- Boston Scientific,Corporation (N...mpany,s major,events and press announcements at th...ieth annual Transcatheter Cardiovascular Therapeut...tober 12 to 17 in Washington, D.C., Boston Scient...,efficacy data on its TAXUS(R) Express2(TM) and se...
Breaking Medicine Technology:12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 212-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 312-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions 4XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 2Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 3Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 4Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 5Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008 6Stabilizing cancer fighting p53 can also shield a metastasis promoter 20062 1Stabilizing cancer fighting p53 can also shield a metastasis promoter 20062 2GlaxoSmithKline Announces 24500 000 in Fellowships at Stanford Graduate School of Business 20058 1GlaxoSmithKline Announces 24500 000 in Fellowships at Stanford Graduate School of Business 20058 2GlaxoSmithKline Announces 24500 000 in Fellowships at Stanford Graduate School of Business 20058 3Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market 20054 1Seahorse Bioscience Enters into Agreement with Primetech Corporation to Bring XF Technology to Japanese Market 20054 2ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 1ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 2ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 3ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 4ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 5ATHENA Clinical Results with Dronedarone 28Multaq 28R 29 29 Highlighted at the World Cardiology Congress 2174 6
... IL -- CytImmune, a clinical stage nanomedicine co...tion of,multifunctional, tumor-targeted therapies ...ican Society of Clinical Oncology (ASCO),Annual me...f a,Phase 1 Clinical Trial of CYT-6901," announced...te conducted and CytImmune Sciences,sponsored Phas...
...ix products from Pharmion,s pipeline provide suppo...ding promising Phase III,data on use of Thalidomid...1, 2007 /PRNewswire-FirstCall/ -- Pharmion,Corpora... studies,investigating the company,s marketed and ...t the American Society of Clinical,Oncology,s (ASC...
Other Medicine Technology:CytImmune Presents Positive CYT-6019 Data During the American,Society of Clinical Oncology Annual Meeting in Chicago 2CytImmune Presents Positive CYT-6019 Data During the American,Society of Clinical Oncology Annual Meeting in Chicago 3Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 2Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 3Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 4Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 5Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 6Pharmion to Present Clinical Data on Commercial and Pipeline,Products at 2007 American Society of Clinical Oncology (ASCO),Meeting 7
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
Sugar-Chex Linearity is a whole blood formulation designed to cover the linear reportable range of the most popular glucose meters. The product meets CAP recommendations of using a control matrix tha
Medicine Products: